Lista de obras -

A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral load

artículo científico publicado en 2014

Antiretroviral therapy for adults infected with HIV: Guidelines for health care professionals from the Quebec HIV care committee

artículo científico publicado en 2011

Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québec's Public Health Insurance Database ⬇️

artículo científico publicado el 1 de julio de 2011

Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-up ⬇️

artículo científico publicado el 9 de noviembre de 2012

Atazanavir and other determinants of hyperbilirubinemia in a cohort of 1150 HIV-positive patients: results from 9 years of follow-up

artículo científico publicado en 2013

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection

article

Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adults

artículo científico publicado en 2009

Canadian consensus statement on HIV and its transmission in the context of criminal law

artículo científico publicado en 2014

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

artículo científico publicado en 2017

Challenges in Initiating Antiretroviral Therapy in 2010 ⬇️

artículo científico publicado el 1 de agosto de 2010

Changes in function of HIV-specific T-cell responses with increasing time from infection

artículo científico publicado en 2010

Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

artículo científico publicado en 2016

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients

artículo científico publicado en 2016

Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts

artículo científico publicado en 2015

Effectiveness and tolerability of oral administration of low-dose salmon oil to HIV patients with HAART-associated dyslipidemia

artículo científico publicado en 2007

Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: a pilot study

artículo científico publicado en 2005

Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal

artículo científico publicado en 2004

Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance

artículo científico publicado en 2009

HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations

scientific article published on January 2013

HIV-associated lipodystrophy syndrome: A review of clinical aspects

artículo científico publicado en 2005

High rates of forward transmission events after acute/early HIV-1 infection

artículo científico publicado en 2007

Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection

artículo científico publicado en 2002

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection

artículo científico publicado en 2015

Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study

artículo científico publicado en 2014

Limiting cardiovascular events associated with HIV and antiretroviral therapy

artículo científico publicado en 2017

Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals.

artículo científico publicado en 2011

Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals

artículo científico publicado en 2007

Negligible Effect of Tenofovir on Atazanavir Trough Concentrations and Genotypic Inhibitory Quotients in the Presence and Absence of Ritonavir ⬇️

artículo científico publicado el 1 de abril de 2013

Nelfinavir and non-nucleoside reverse transcriptase inhibitor-based salvage regimens in heavily HIV pretreated patients

artículo científico publicado en 2003

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

artículo científico publicado en 2013

Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada

artículo científico publicado en 2017

Predicting tipranavir and darunavir resistance using genotypic, phenotypic, and virtual phenotypic resistance patterns: an independent cohort analysis of clinical isolates highly resistant to all other protease inhibitors

artículo científico publicado en 2010

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

artículo científico publicado en 2006

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors

artículo científico publicado en 2016

Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen

artículo científico publicado en 2007

Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1h/y and HLA-B*57

artículo científico publicado en 2011

Recognizing cognitive and psychiatric changes in the post-highly active antiretroviral therapy era.

artículo científico publicado en 2012

Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study

artículo científico publicado el 2 de mayo de 2012

Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015.

artículo científico publicado en 2018

Subtype diversity associated with the development of HIV‐1 resistance to integrase inhibitors ⬇️

artículo científico publicado el 25 de febrero de 2011

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.

artículo científico publicado en 2017

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection

artículo científico publicado en 2016

Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation ⬇️

artículo científico publicado el 14 de agosto de 2013

Lista de obras de

A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral load

Antiretroviral therapy for adults infected with HIV: Guidelines for health care professionals from the Quebec HIV care committee

Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québec's Public Health Insurance Database ⬇️

Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-up ⬇️

Atazanavir and other determinants of hyperbilirubinemia in a cohort of 1150 HIV-positive patients: results from 9 years of follow-up

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection

Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adults

Canadian consensus statement on HIV and its transmission in the context of criminal law

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

Challenges in Initiating Antiretroviral Therapy in 2010 ⬇️

Changes in function of HIV-specific T-cell responses with increasing time from infection

Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients

Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts

Effectiveness and tolerability of oral administration of low-dose salmon oil to HIV patients with HAART-associated dyslipidemia

Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: a pilot study

Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal

Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance

HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations

HIV-associated lipodystrophy syndrome: A review of clinical aspects

High rates of forward transmission events after acute/early HIV-1 infection

Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection

Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study

Limiting cardiovascular events associated with HIV and antiretroviral therapy

Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals.

Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals

Negligible Effect of Tenofovir on Atazanavir Trough Concentrations and Genotypic Inhibitory Quotients in the Presence and Absence of Ritonavir ⬇️

Nelfinavir and non-nucleoside reverse transcriptase inhibitor-based salvage regimens in heavily HIV pretreated patients

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada

Predicting tipranavir and darunavir resistance using genotypic, phenotypic, and virtual phenotypic resistance patterns: an independent cohort analysis of clinical isolates highly resistant to all other protease inhibitors

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors

Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen

Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57

Recognizing cognitive and psychiatric changes in the post-highly active antiretroviral therapy era.

Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study

Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015.

Subtype diversity associated with the development of HIV‐1 resistance to integrase inhibitors ⬇️

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection

Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation ⬇️

Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1h/y and HLA-B*57